600518 Stock Overview
Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese herbal medicines in China.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Kangmei Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥1.96 |
| 52 Week High | CN¥2.50 |
| 52 Week Low | CN¥1.68 |
| Beta | 0.72 |
| 1 Month Change | -5.77% |
| 3 Month Change | 5.38% |
| 1 Year Change | -18.33% |
| 3 Year Change | -15.52% |
| 5 Year Change | -69.66% |
| Change since IPO | 45.30% |
Recent News & Updates
Kangmei Pharmaceutical's (SHSE:600518) Performance Is Even Better Than Its Earnings Suggest
May 06
Kangmei Pharmaceutical Co., Ltd.'s (SHSE:600518) Price Is Out Of Tune With Revenues
Apr 10Shareholder Returns
| 600518 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -1.5% | 4.0% | 2.2% |
| 1Y | -18.3% | -5.0% | -10.2% |
Return vs Industry: 600518 underperformed the CN Pharmaceuticals industry which returned -6.2% over the past year.
Return vs Market: 600518 underperformed the CN Market which returned -11.3% over the past year.
Price Volatility
| 600518 volatility | |
|---|---|
| 600518 Average Weekly Movement | 4.6% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in CN Market | 11.0% |
| 10% least volatile stocks in CN Market | 4.3% |
Stable Share Price: 600518 has not had significant price volatility in the past 3 months.
Volatility Over Time: 600518's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 4,409 | Guowei Liu | www.kangmei.com.cn |
Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese herbal medicines in China. It also offers chemical medicines and health food; and operates hospitals and pharmacies. Kangmei Pharmaceutical Co., Ltd.
Kangmei Pharmaceutical Co., Ltd. Fundamentals Summary
| 600518 fundamental statistics | |
|---|---|
| Market cap | CN¥27.17b |
| Earnings (TTM) | CN¥160.40m |
| Revenue (TTM) | CN¥4.93b |
169.4x
P/E Ratio5.5x
P/S RatioIs 600518 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600518 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.93b |
| Cost of Revenue | CN¥4.20b |
| Gross Profit | CN¥727.35m |
| Other Expenses | CN¥566.95m |
| Earnings | CN¥160.40m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.012 |
| Gross Margin | 14.75% |
| Net Profit Margin | 3.25% |
| Debt/Equity Ratio | 1.0% |
How did 600518 perform over the long term?
See historical performance and comparison